Related Experiment Video
Updated: Nov 4, 2025

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
RAP2A promotes apoptosis resistance of hepatocellular carcinoma cells via the mTOR pathway
Jing-Ru Yang1, Xiao-Ling Ling1, Quan-Lin Guan2
1The Department of Oncology, The First Hospital of Lanzhou University, Donggang West Road, Chengguan District, Lanzhou, 730000, Gansu Province, People's Republic of China.
Abstract:
Hepatocellular carcinoma (HCC) is the most common digestive system cancer. In the current study, we investigated the biological effects of Ras-related protein Rap-2a (RAP2A), a GTPase protein, in HCC tissues and cells. We found that RAP2A was upregulated in HCC tissues and cells. RAP2A knockdown could effectively inhibit the proliferation of HCC cells and weaken its apoptosis resistance. In terms of its action mechanism, RAP2A may be involved in activating the mTOR signaling pathway. Therefore, we believe that RAP2A is abnormally highly expressed in HCC tissues and promotes tumor cell proliferation and apoptosis resistance by activating the mTOR signaling pathway, and it may serve as a potential target for HCC treatment.
Insights
Ras-related protein Rap-2a (RAP2A) is highly expressed in hepatocellular carcinoma (HCC), promoting tumor cell growth and survival. Inhibiting RAP2A may offer a new treatment strategy for this common digestive system cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Hepatocellular carcinoma (HCC) is a prevalent digestive system cancer.
- Understanding the molecular mechanisms driving HCC progression is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the biological role and mechanism of Ras-related protein Rap-2a (RAP2A) in HCC.
- To evaluate RAP2A as a potential therapeutic target for HCC.
Main Methods:
- Analysis of RAP2A expression in HCC tissues and cells.
- Assessment of the effects of RAP2A knockdown on HCC cell proliferation and apoptosis.
- Investigation of RAP2A's involvement in the mTOR signaling pathway.
Main Results:
- RAP2A was found to be upregulated in HCC tissues and cells.
- Knockdown of RAP2A inhibited HCC cell proliferation and reduced resistance to apoptosis.
- RAP2A appears to activate the mTOR signaling pathway.
Conclusions:
- Abnormal high expression of RAP2A promotes HCC cell proliferation and apoptosis resistance.
- RAP2A may serve as a potential therapeutic target for hepatocellular carcinoma.
More Related Videos
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
09:31Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
MAPK Signaling Cascades
The Extrinsic Apoptotic Pathway